|Application:||Gene expression microarray analysis|
|Number of samples:||4|
|Release date:||Sep 26 2015|
|Last update date:||Sep 27 2017|
|Diseases:||Urinary Bladder Neoplasms, Glycogen Storage Disease Type III, Neoplasms|
|Dataset link||Expression data from UMUC3 cells transduced with non-targeted shRNA and shRNA specific to AGL|
AGL knockdown in UMUC3 was achieved using shRNA TRCN0000035082 (Sigma-Aldrich). MISSION® pLKO.1-puro non-mammalian shRNA control plasmid DNA (SHC002, Sigma-Aldrich) was used as control. Each condition had two biological replicates.